Back to homepage | Congress of the Month
Print view
 
 

Neuropsychiatric Drug Development Summit 2018

Hanson Wade

30.07.2018 - 01.08.2018
Courtyard Boston Cambridge
777 Memorial Drive
Cambridge, 02139 Boston
USA

Conference themes

Globally it's estimated 1 in 5 people suffer from neuropsychiatric disorders. This figure, combined with drugs that are showing little or no response is making neuropsychiatric disorders a huge unmet clinical need.
The neuropsychiatric drug development field has been stifled for decades by a lack of scientific progress in understanding the brain and costly and challenging clinical trials.

Notes

Speakers: Jim Cassella, Niels Plath, Janet Nicholson, Brigitte Robertson, Mickey Matsumoto, Srinivas Rao, Mark Smith, Christopher Missling, Venkatesha Murthy, Eva Kohegyi

Languages
English
Fees

USD 699,00

Enquiries and Registration

Jenny Barlow
info@hansonwade.com

 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Anästhesie in Entwicklungsländern e. V.Charité International AcademyÖsterreichische Akademie der ÄrzteÖsterreichisches Rotes KreuzÄrzte der WeltCenter of ExcellenceSwiss Tropical and Public Health InstitutenewTree

Facebook

Give us your professional opinion

Start survey

Start survey